Skip to Main Content

Try STAT+ TODAY

precision medicine

Most Read

In the Lab Elizabeth Cooney

STAT Plus: New findings about little-studied cellular compartments could help make chemo more effective

Health Elizabeth Cooney

STAT Plus: Recapping ASCO 2020, talking cancer therapy combinations, and looking to the future

In the Lab Sharon Begley

Our body systems age at different rates, study finds, pointing to personalized care to extend healthy life

Health Tech Casey Ross

How an AI expert took on his toughest project ever: writing code to save his son’s life

In the Lab Sharon Begley

The boy was dying. Zebrafish helped save his life

In the Lab Sharon Begley

Buffalo gave us spicy wings and the ‘book of life.’ Here’s why that’s undermining personalized medicine

First Opinion Jim Tananbaum

Pharma and biotech should embrace ‘Medicare for all,’ not defeat it

First Opinion Michael J. Joyner and Nigel Paneth

Precision medicine’s rosy predictions haven’t come true. We need fewer promises and more debate

All Coverage

Health Elizabeth Cooney

STAT Plus: ‘We shouldn’t leave anybody behind’: Inequities in cancer genomics undercut promise of precision medicine

Biotech Elizabeth Cooney

STAT Plus: Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers

advertisement

Biotech Matthew Herper

STAT Plus: Turning Point releases positive data for targeted cancer drug, points to more rapid FDA filing

Health Elizabeth Cooney

Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment

Biotech Elizabeth Cooney

STAT Plus: Startup Spotlight: Aiming to speed precision cancer therapies to children

First Opinion Richard Cooper and Nigel Paneth

Precision medicine: course correction urgently needed

First Opinion David A. Pearce

We need better regulation of stem cell therapies, especially rogue clinics

First Opinion Gwen Nichols

Precision medicine has a blind spot: children with cancer

First Opinion Amy DuRoss

To make advanced therapies, we need to industrialize personalization

In the Lab Karen Weintraub

Growing tumors in a dish, scientists try to personalize pancreatic cancer treatment

First Opinion Edward Abrahams

Personalized treatments may be threatened by drug cost-containment proposals

Health Tech Casey Ross

STAT Plus: What if AI in health care is the next asbestos?

First Opinion Rahul Desikan

I have ALS. I wish a polygenic analysis had told me it was coming

Health Rebecca Robbins, Adam Feuerstein and Damian Garde

STAT Plus: He went hunting for gold-standard research on artificial intelligence in medicine — and didn’t find much

First Opinion Harris A. Gelbard

Multi-target drugs should be in the pharma pipeline along with precision drugs

Business Rebecca Robbins

With human drugs, a Silicon Valley startup hopes to deliver precision medicine to dogs

First Opinion Lee D. Cooper

Genetic testing plus IVF can sidestep genetic disease and reduce the need for high-priced therapies

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

Health Liz Szabo — Kaiser Health News

Pricey precision medicine often financially toxic for cancer patients

First Opinion Richard G. Hamermesh and Kathy E. Giusti

Precision medicine needs a business mindset in order to flourish

First Opinion Joel C. White

Administrative delays threaten the promise of the 21st Century Cures Act

First Opinion Franklin W. Maddux

Kidney disease is a killer. More precise classification can help tame it

First Opinion Robert W. Dubois

Paying for therapies that cure: innovative solutions needed

First Opinion Akbar K. Waljee, Sameer D. Saini and Brahmajee K. Nallamothu

Doctors could prescribe drugs more accurately — if they could get the data

First Opinion Chadi Nabhan

Barriers to genomic testing get in the way of precision medicine